Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ISR-alpha anticorps (AA 701-760)

L’anticorps Lapin Polyclonal anti-ISR-alpha a été validé pour IF (cc), IF (p), WB, FACS, IHC (p), ELISA et IHC (fro). Il convient pour détecter ISR-alpha dans des échantillons de Humain et Rat. Il y a 1 publication disponible.
N° du produit ABIN724145

Aperçu rapide pour ISR-alpha anticorps (AA 701-760) (ABIN724145)

Antigène

Voir toutes ISR-alpha Anticorps
ISR-alpha (Insulin Receptor alpha (ISR-alpha))

Reactivité

  • 72
  • 41
  • 11
  • 3
  • 3
  • 2
  • 2
  • 1
Humain, Rat

Hôte

  • 55
  • 17
Lapin

Clonalité

  • 36
  • 33
  • 3
Polyclonal

Conjugué

  • 18
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp ISR-alpha est non-conjugé

Application

  • 26
  • 25
  • 18
  • 14
  • 13
  • 10
  • 10
  • 10
  • 8
  • 5
  • 3
  • 2
  • 2
  • 1
Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro))
  • Épitope

    • 22
    • 15
    • 15
    • 2
    • 1
    AA 701-760

     Réactivité croisée

    Humain, Rat

    Homologie

    Mouse,Dog,Cow,Sheep,Pig,Horse,Chicken,Rabbit

    Purification

    Purified by Protein A.

    Immunogène

    KLH conjugated synthetic peptide derived from human Insulin Receptor alpha

    Isotype

    IgG
  • Indications d'application

    WB 1:300-5000
    ELISA 1:500-1000
    FCM 1:20-100
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

    Date de péremption

    12 months
  • Xiao, Ma, Zhao, Smith, Huang, Jones, Persaud, Pingitore, Dorling, Lechler, Lombardi: "APT070 (mirococept), a membrane-localizing C3 convertase inhibitor, attenuates early human islet allograft damage in vitro and in vivo in a humanized mouse model." dans: British journal of pharmacology, Vol. 173, Issue 3, pp. 575-87, (2016) (PubMed).

  • Antigène

    ISR-alpha (Insulin Receptor alpha (ISR-alpha))

    Autre désignation

    Insulin Receptor alpha

    Sujet

    Synonyms: HHF5, CD220, Insulin receptor, IR, INSR, Insulin receptor subunit alpha, PRO_0000016687

    Background: Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosines residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD, regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway.

    ID gène

    3643

    UniProt

    P06213
Vous êtes ici:
Chat with us!